|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 16802132.7 (espacenet) (Federated) (European Patent Register), 20161104 | | Patent/reg. no. and date | DK/EP 3370756, 20200408 | | Publication date | 20180912 | | Priority no. and date | GR 20150100486, 20151106 | | EP pub. no. and date |
EP 3370756 20180912 | | Effective date | | | Applicant/owner | Genesis Pharma SA, 270 Kifissias Avenue
15232 Athens, GR | | Applicant ref. no. | 1543178 | | Inventor | VOGIATZIS, George, Genesis Pharma SA
270 Kifissias Avenue
15232 Athens, GR | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 38/13 (2006.01) , A61K 38/26 (2006.01) , A61P 9/10 (2006.01) | | Title | KOMBINATION AF CANRENOAT OG EXENATID | | Int. application no. | IB2016001582 | | Int. publication no. | WO2017077378 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
